FDA Inspection 1168204 — Smith Drug Company
The FDA completed an inspection of Smith Drug Company on Apr 26, 2022 in Spartanburg, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 26, 2022
- Fiscal Year
- 2022
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Spartanburg, SC (United States)